Activin A, a multifunctional factor of the transforming growth factor-beta (TGF-) superfamily, is mainly produced by microglia and macrophages, and its anti-inflammatory and pro-inflammatory activities are both related to macrophage functions. However the direct effect of activin A on the rest macrophages in vivo remains unclear. In the present study, the results showed that activin A not only increased NO and IL-1 release, but also promoted phagocytic abilities of mouse peritoneal macrophages in vitro and in vivo, whereas it did not influence MHC I and MHC II expression. Moreover, we found that activin A significantly upregulated the expressions of CD14 and CD68, markers of mature macrophages, on the surface of macrophages in vitro and in vivo. These data suggest that activin A can induce primary macrophage maturation in vitro and in vivo, but may not trigger the acquired immune response via regulating expression of MHC molecules involved in presentation of antigen.
Introduction
Activin is a multifunctional factor of transforming growth factor-beta (TGF-) superfamily (1) (2) (3) . Homo-or heterodimerization of two inhibin β subunits (A and B) form three types of activins, activin A (AA), activin B (BB) and activin AB (AB). Activin A acts as a potential anti-inflammatory cytokine, and is involved in the regulation of acute phase response in inflammatory diseases (4) (5) (6) (7) (8) . Meanwhile, activin A is also a pro-inflammatory factor, which is involved in the pathogenesis of fibrotic human diseases (8) (9) (10) .
Activin A is mainly produced by microglia and macrophages and its anti-inflammatory and pro-inflammatory activities are both related to macrophage functions (5, (11) (12) (13) . When induced by inflammatory stimuli, tissue resident macrophages become activated and release proinflammatory mediators, interleukin 1 (IL-1), IL-6 and nitric oxide (NO) to initiate defense responses. At the same time, pinocytic and phagocytic activities of macrophages are enhanced greatly, and the expression of MHC molecules that are involved in presentation of antigen is increased. Previous studies have demonstrated that as an anti-inflammatory cytokine, activin A can inhibit the function of lipopolysaccharide (LPS)-activated macrophages in vitro and in vivo, and exert antagonistic effect on IL-6 and IL-11 (13) (14) (15) (16) . However, the latest study reveals that insulin results in regulation of macrophage activity in response to endotoxin through the release of activin A (17) , and our studies report that activin A can induce the production of inflammatory mediator NO from mouse peritoneal macrophages in vitro and activation of mouse macrophage cell line RAW264.7 cells directly (11, 18) . However, effect of activin A on activation and maturation of rest macrophages in vivo are not well discovered.
In the present study, the effect of activin A on rest macrophages was investigated in mouse peritoneal macrophages. We found that activin A not only increased the production of NO and IL-1, promoted phagocytic activities of mouse peritoneal macrophages in vitro and in vivo, but also enhanced the expressions of CD14 and CD68, which are markers of mature macrophages. These data suggest that activin A can directly induce primary macrophage maturation and activation in vitro and in vivo.
Materials and Methods

Reagents and antibodies
Recombinant human activin A (Act) was obtained from R&D (Minneapolis, MN 55413). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) were purchased from Sigma (St. Louis, MO, USA); IL-1 ELISA kit and mouse monoclonal antibody against CD14 were purchased from eBioscience (San Diego, CA, USA); and antibodies against MHCI, MHCII, CD68 were obtained from Serotec (Oxford, UK).
Culture of mouse peritoneal macrophages
Female C57BL/6 mice at 8 wk of age were obtained from the Laboratory Research Center of Jilin University (Changchun, China). Mouse peritoneal macrophages were obtained by lavaging the peritoneal cavity with 5 ml of ice-cold sterile RPMI 1640 medium, and cultured in a humidified incubator containing 5% CO 2 at 37°C in 10% fetal calf serum (FCS)-RPMI 1640 medium for 1 h (11). After incubation, the nonadherent cells were removed by washing with serum-free medium and the adherent cells were seeded in 12-well plates at a density of 1  10 6 cells/well and incubated in 5% FCS-RPMI 1640 medium in the presence or absence of activin A (0.8 -10 ng/ml) for 24 h, respectively.
Detection of NO levels
NO levels in the culture supernatant were determined by NO kit according to the manufacturer's protocol (NJJC, Nanjing, China). The absorbance was measured at 540 nm on an automated microtiter plate reader. Nitrite concentration was calculated by comparison with a standard curve generated with sequential dilutions of standard sodium nitrite.
Enzyme-linked immunosorbent assay for IL-1
IL-1β levels were measured in the culture supernatant by using a commercial two-site mouse IL-1 enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer's protocol. The absorbance was then detected at 450 nm to evaluate the IL-1 levels.
In vitro assay of mouse peritoneal macrophage phagocytosis
To evaluate phagocytic capability of mouse macrophages, chicken red blood cells (cRBC) were used as antigen particles. Macrophages were treated with or without activin A (2 ng/ml or 5 ng/ml) in 5% FCS-RPMI 1640 medium at 37°C in a humidified incubator containing 5% CO 2 at 37°C for 24 h, and then macrophages were incubated in 5% FCS-RPMI 1640 medium containing 0.5% cRBC for 1 h. Macrophages were rinsed with pH7.4, 0.01 mol/L phosphate-buffered saline (PBS). After fixed with 4% paraformaldehyde, the cells were stained with Wright-Giemsa dye. Phagocytosed cRBC were examined with light microscopy and a minimum of 200 macrophages were counted in each well. The phagocytosis ratio and index of macrophages were calculated as follows: phagocytosis ratio (PR) = number of macrophages phagocyting chicken red blood cells / number of macrophages; phagocytosis index (PI) = number of chicken red blood cells phagocytosed by macrophages / number of macrophages (19) .
In vivo assay of mouse peritoneal macrophage phagocytosis Mice were injected with activin A (10 ng/200 l or 20 ng/200 l) or 200 l of PBS intraperitoneally (20) . On the next day, 500 μl of 2% cRBC were injected into the abdominal cavity 30 min before the mice were sacrificed. Then the peritoneal cavity was washed with 1 ml of PBS under aseptical conditions to collect peritoneal macrophages. The macrophages were incubated on a slide at 37°C in a humidified incubator containing 5% CO 2 at 37°C for 30 min. After fixed with 4% paraformaldehyde solution, adherent cells were stained with Wright-Giemsa dye and observed through light microscopy. Both PR and PI were also calculated as described above. percentage of fluorescence positive cells.
Analysis of mouse peritoneal macrophage proliferation
Mouse peritoneal macrophages were seeded into 96-well culture plates at a density of 2 × 10 5 cells/ml, and incubated in 200 l of 5% FCS-RPMI 1640 medium in the presence or absence of activin A (2 -10 ng/ml) at 37°C for 24 h, respectively. The viable cells were stained with MTT for 4 h. Media were removed and the formazan crystala was dissolved by adding 200 l of dimethylsulfoxide (DMSO). Absorbance was then detected at 570 nm to express the cell viabilities (21) .
Statistical analysis
Data were expressed with means ± SD and statistic analysis was performed by Student's t test. p < 0.05 was considered statistically significance.
Results
Activin A induces NO and IL-1β productions in mouse peritoneal macrophages
Macrophages have shown to be activated and secreted a variety of inflammatory mediators in response to inflammatory stimuli. In this study, we found that activin A increased NO and IL-1 productions significantly from mouse peritoneal macrophages in a dose-dependent manner (Figure 1 ). These data suggested that activin A might directly inspire activation of rest mouse peritoneal macrophages.
Activin A enhances phagocytic activities of mouse peritoneal macrophages in vitro and in vivo
Phagocytic activities are the most important functions of activated macrophages in innate immune response. To assess direct effect of activin A on macrophage phagocytosis, the phagocytic activities of macrophages to cRBC were examined in vitro and in vivo. As shown in Figure 2 , Activin A promoted the phagocytic activities of mouse peritoneal macrophages greatly in vitro and in vivo. We also found that activin A-activated macrophages had obviously morphological changes from round cells to irregular cells and the activated macrophages with an irregular shape had phagocytic ability to cRBC (Figure 2A) . The above results revealed that by promoting phagocytic activities of macrophages in vivo, activin A played critical roles in macrophage-mediated innate immune response. peritoneal macrophages (Figure 3 ). These data indicated that activin A may have no effect on antigen presenting ability of mouse macrophages.
Activin A upregulates CD68 and CD14 expressions on mouse peritoneal macrophages
In the present study, we further examined the expressions of CD68 and CD14, surface markers of mature macrophages, on mouse peritoneal macrophages by flow cytometry, and found that their expressions were up-regulated on mouse peritoneal macrophages when treated by activin A in vitro and in vivo (Figure 4 ). These results suggested that activin A might promote the activation and maturation of mouse macrophages in vivo.
Activin A has no effect on the proliferation of mouse peritoneal macrophages To further study the roles of activin A on regulation of activities of mouse peritoneal macrophages, proliferation of mouse peritoneal macrophages was examined by MTT colorimetric method. The results revealed that there was no significant difference in proliferation of mouse peritoneal macrophages after 24 h treatment with activin A ( Figure 5 ). These findings suggest that activin A induces the activation and maturation of mouse peritoneal macrophages, but do not influence macrophage proliferation.
Discussion
Activin A plays a critical role in many physiological processes, including regulation of secretion of folliclestimulating hormone (FSH) from anterior pituitary, differentiation of erythroblasts and embryonic development (22) (23) (24) . Our previous studies have reported that activin A can promote inflammatory mediator NO production from mouse peritoneal macrophages in vitro and induce the activation of mouse macrophage cell line RAW264.7 cells directly (11, 18) , which suggest that activin A may contribute to macrophage activation in the early stage of inflammation. Activated macrophages secrete several inflammatory mediators including IL-1, IL-6 and NO, which may result in tissue damage and systemic inflammation. In this study, we found that activin A increased not only NO release, but also IL-1β production from mouse peritoneal macrophages. In addition to secreting inflammatory mediators, macrophages can also phagocytose large antigen particles, including various pathogenic microorganism, apoptotic cells and tumor cells. We found that both the percentage of phagocytic macrophages and the average number of ingested cRBC were increased after treatment with activin A in vitro and in vivo. Our results reveal a regulatory role of activin A in the phagocytic process and provide further evidence of activin A-induced host resistance against invading microbes, as well as suggest that activin A is a critical direct activator for mouse rest peritoneal macrophages.
Macrophages play an essential role in the activation of the adaptive immune system via processing and presenting antigens. Although we have found that activin A upregulated MHC II expression on mouse macrophage cell line RAW264.7 cells (18) , our data in the present study showed that activin A did not alter MHC I and MHC II expressions on surface of mouse peritoneal macrophages. The reason for the discrepancy could be the different sources of macrophages, and macrophage-like cell line RAW264.7 cells may not reflect all the features of macrophages. These data indicate that activin A may not affect the antigen presenting activity of mouse macrophages in vivo.
CD68 and CD14 are cell membrane molecule markers for monocytes/macrophages (25, 26) , highly expressed on activated and mature monocyte/macrophage surface, and CD14 acts as one component of CD14/TLR4/MD2 receptor complex which binds the LPS of gram negative bacteria and facilitates destruction of microbes and induction of various cytokines secretion involved in triggering a wide array of immune responses. We found that activin A significantly increased CD14 and CD68 expression on surface of mouse peritoneal macrophages. Meanwhile, there was no significant change in peritoneal macrophage proliferation after treated with activin A. These data suggest that activin A can induce the activation and maturation of mouse peritoneal macrophages, but do not influence cell proliferation.
Macrophages are present in all tissues of human body where they normally assist in guarding against invading pathogens and regulate tissue remodeling. However, they are also known to accumulate in large numbers in inflammation sites, and might cause tissue injury. Our previous studies have found that activin A in vitro and in vivo plays an important role in down-regulating the activation of LPSinduced mouse peritoneal macrophages, suggesting activin A may have the potential to inhibit over-inflammatory response in the late stage of inflammation (11, 20) . Our present study provides further insight toward the potential roles that activin A plays directly in the regulation of rest macrophage activation and maturation in the early stage of inflammation response.
Taken together, activin A may play important regulatory roles in mouse peritoneal macrophages by promoting the maturation and activation of mouse rest macrophages in the early phage of inflammation and inhibiting the overactivation of activated macrophages in the late stage of inflammation. Thus, activin A might have the potential for treatment of macrophage-mediated inflammatory diseases through dual modulation of macrophage functions.
